FDA-Drug2025-12-24Class IIICHEMICAL
Somerset Therapeutics cisatracurium besylate injection recalled for subpotent drug strength
LABEL MIX UPNationwide distribution
Check cisatracurium besylate vials for affected lots
Somerset Therapeutics is recalling specific lots of cisatracurium besylate injection because testing found the drug contains less active ingredient than labeled. The affected vials may not work as intended during medical procedures. No injuries have been reported.
- If you have cisatracurium besylate with lot A240438 (expires 1/31/26) or A250125 (expires 8/31/26), do not use it
- Contact your pharmacy or hospital to verify whether your supply is affected
- Follow your healthcare provider's instructions for alternative medications if needed
Hazard
Subpotent product:out of specification assay results observed during long term stability testing.
Sold states
Nationwide in the USA
Affected count
52,340 5mL vials
Manufactured in
300 Franklin Square Dr, Somerset, NJ, United States
Products
Cisatracurium Besylate Injection USP, 10 mg/5 mL* (2mg/mL), 10 x 5 mL Single-dose Vials per Carton, Rx Only, Manufactured for: Somerset Therapeutics, LLC, Hollywood, FL 33024, Made in India, Single-dose 5 mL vial NDC 70069-141-01; 10x5 mL single dose vial per Carton NDC 70069-141-10.
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0236-2026Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief